Navigation Links
Amsterdam Molecular Therapeutics Receives Request for Further Information From CHMP on Glybera®
Date:2/21/2012

AMSTERDAM, The Netherlands, February 21, 2012 /PRNewswire/ --

Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that it has received a request to provide additional information to the Committee for Human Medicinal Products (CHMP) on Glybera® (alipogene tiparvovec) by March 8, 2012. The CHMP request follows the announcement on January 30, 2012 that the European Commission Standing Committee was requesting additional information from the CHMP. The CHMP has indicated that a final decision on Glybera could be made by May 2012.

Glybera is a gene therapy for patients with the genetic disorder LPLD, a very rare inherited condition that is associated with increased levels of chylomicrons. These particles carry certain types of fat in the blood, which because they are not removed from the body can cause recurrent bouts of pancreatitis. There is no treatment currently available for these patients.

On October 23, 2011, AMT received a non-approvable opinion from the CHMP (following a re-examination of the marketing approval dossier originally rejected in June 2011) despite a recommendation to approve Glybera by the Committee for Advanced Therapies (CAT). The CAT is an expert body implemented by the European Commission to prepare and advise the CHMP on decisions regarding advanced therapeutics, in particular gene and cell therapies. 

AMT's proposed acquisition of assets by uniQure BV announced on February 17, 2012, was developed on the basis that Glybera is not approvable. This transaction will proceed as planned. In the event that Glybera could be commercialized in Europe, uniQure will evaluate how achieving this important milestone could be realized most efficiently.

About Glybera®

AMT has developed Glybera as a treatment for patients with the genetic disorder lipoprotein lipase deficiency.

LPLD is an orphan disease for which no treatment ex
'/>"/>

SOURCE Amsterdam Molecular Therapeutics (AMT) B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
2. Pharma and Food Thought Leaders Set to Converge in Amsterdam Next April 2011
3. Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
4. Amsterdam Molecular Therapeutics Glybera(R) Significantly Reduces the Risk of Pancreatitis in LPLD Patients
5. Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
6. Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera® Marketing Authorisation and Requests Further Information From the CHMP
7. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
8. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
10. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
11. Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... DUBLIN , June 26, 2015 ... of the "Vitamin D Market by Analog, Application, End-User ... report to their offering. This market is ... use of vitamin D in different applications and rising opportunities ... China , Italy , and ...
(Date:7/2/2015)... , July 2, 2015 Numotion,s Board of ... announced that Tamas Feitel has joined the ... Numotion after a highly successful 18 year career at ... driving strategy, profitability, and productivity to result in significant ... position was Chief Financial Officer for GE Healthcare Global ...
(Date:7/2/2015)... The report "Silage Inoculants & Enzymes Market ... Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type & Geography - ... Enzymes Market is expected to reach $489.05 Million by ... 2020. Browse 75 market Tables and ... P ages and an in-depth TOC on ...
Breaking Medicine Technology:Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3Numotion Names Tamas Feitel Chief Financial Officer 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4
... IRVINE, California , and AMSTERDAM , ... molecular cancer diagnostics, announced today that company,CEO Dr. Bernhard ... July 20 ,in Washington D.C. on the ... Food and Drug Administration (FDA) and,Center for Devices and Radiological ...
... , DETROIT , July 15 Caraco Pharmaceutical ... July 12, 2010 , NYSE Amex notified the Company that it ... standards that its audit committee be comprised of three independent members. ... of its non-compliance with Section 803(B)(2)(a) of NYSE Amex Company Guide ...
Cached Medicine Technology:Agendia to Provide Testimony at Public Meeting on FDA Oversight of Laboratory-Developed Tests 2Caraco Pharmaceutical Laboratories, Ltd. Receives Notice Regarding NYSE Amex Continued Listing Standards 2
(Date:7/3/2015)... ... ... will hopefully be getting a large donation of canned food items at the end ... making it their mission to collect as many canned items as possible. Donations do not ... as well. As part of the canned food drive, these local chiropractors will be donating ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top ... mesothelioma with even minimal asbestos exposure. Click here to read the complete story ... of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed mice ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County ... 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William ... practical points of investigating these types of cases. , Each year, New York ...
(Date:7/3/2015)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... Director of its Frisco facility. , “We are pleased to announce that Dr. Manzanares ... Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Manzanares received ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... The Celebrity ... or cocktail dresses similar to those of celebrities will have the opportunity to get ... at checkout. This ensures that people do not have to use coupon codes or ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2
... fall season can be just as bad as the ... over-the-counter (OTC) medicine; however, can quickly becoming an// overwhelming ... shelf of products that often times have very similar ... pharmacy of the Philadelphia College of Pharmacy at University ...
... the American Heart Association's 60th Annual Fall Conference of the ... high blood// pressure may be at risk of sleep breathing ... high blood pressure, 60 % of whom were affected by ... upper airway obstructions cause SDB. These obstructions can be complete ...
... new front in the war against flu, researchers at ... a novel compound that confers broad protection// against influenza ... work, reported online this week (Oct. 4, 2006) in ... peptide -- a small protein molecule -- that effectively ...
... that reviews of drugs, which are supported by the ... conclude// sympathetically as compared to independent reviews, reveals a ... that bias in drug trials is a common phenomenon ... which can have a more unbiased and systematic approach ...
... 20 Cuban deaf and blind children can hear now, ... has revolutionized the world of profound// neuro-sensorial auditory deficiency. ... International Health Centre in Havana, the Prensa Latina news ... speaking signs into electric signals, partially restoring the hearing ...
... premier hospital, the All India Institute of Medical Sciences (AIIMS), ... and garbage littered across the campus. ,In the last ... exposed serious flaws within India's best known public health facility ... 26 resident doctors, medical students and staff being admitted to ...
Cached Medicine News:Health News:Allergy OTC Medicines–Speak With Your Pharmacis 2Health News:Allergy OTC Medicines–Speak With Your Pharmacis 3Health News:Hypertensive Kids at risk of sleep disordered breathing 2Health News:Hypertensive Kids at risk of sleep disordered breathing 3Health News:New Drug Blocks Influenza, Including Bird Flu Virus 2Health News:New Drug Blocks Influenza, Including Bird Flu Virus 3Health News:AIIMS Campus - A Breeding Ground for Mosquitoes 2Health News:AIIMS Campus - A Breeding Ground for Mosquitoes 3
... The Spectrum® Tissue Repair System is designed ... and shoulder soft tissue. It features ... roller system. Interchangeable suture hooks allow ... The Spectrum® Tissue Repair System is ...
... The Mini-Open Rotator Cuff Repair ... by,reducing procedure time, incision size and ... system,augments other rotator cuff repair systems ... of,three sizes of matched cortical gauge ...
Threaded cannula with cannulated obturator for use with Acufex Suture Punch; sterile packs, box of 10....
Threaded cannula for use with Suretac® II, sterile packs, box of 10....
Medicine Products: